Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 10, 2019

SELL
$164.61 - $190.37 $2,798 - $3,236
-17 Closed
0 $0
Q1 2019

Apr 02, 2019

BUY
$163.73 - $194.7 $2,783 - $3,309
17 New
17 $3,000
Q3 2018

Oct 30, 2018

SELL
$167.73 - $192.74 $1,174 - $1,349
-7 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$151.6 - $177.13 $1,061 - $1,239
7 New
7 $1,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dubuque Bank & Trust CO Portfolio

Follow Dubuque Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.